Key Record Dates
| ClinicalTrials.gov Identifier: | NCT00945724 |
|---|---|
| Brief Title: | Safety and Feasibility Study of Combination of State of Art Chemoimmunotherapy, Intensive Central Nervous System Prophylaxis and Scrotal Irradiation to Treat Primary Diffuse Large B-cell Lymphoma of Testis (IELSG30) |
| First Submitted : | July 23, 2009 |
| First Submitted that Met QC Criteria : | July 23, 2009 |
| First Posted : | July 24, 2009 (Estimate) |
| Last Update Submitted that Met QC Criteria : | June 4, 2021 |
| Last Update Posted : | June 7, 2021 |